Biobanking in the 21st Century pp 165-169 | Cite as
A Data-Centric Strategy for Modern Biobanking
Abstract
Biobanking has been in existence for many decades and over that time has developed significantly. Biobanking originated from a need to collect, store and make available biological samples for a range of research purposes. It has changed as the understanding of biological processes has increased and new sample handling techniques have been developed to ensure samples were fit-for-purpose.
As a result of these developments, modern biobanking is now facing two substantial new challenges. Firstly, new research methods such as next generation sequencing can generate datasets that are at an infinitely greater scale and resolution than previous methods. Secondly, as the understanding of diseases increases researchers require a far richer data set about the donors from which the sample originate.
To retain a sample-centric strategy in a research environment that is increasingly dictated by data will place a biobank at a significant disadvantage and even result in the samples collected going unused. As a result biobanking is required to change strategic focus from a sample dominated perspective to a data-centric strategy.
Keywords
Biobanking Big data Biobanking strategyReferences
- 1.De Souza YG, Greenspan JS (2013) Biobanking past, present and future: responsibilities and benefits. AIDS (London, England) 27(3):303CrossRefGoogle Scholar
- 2.Eiseman E, Haga SB (1999) Handbook of human tissue sources. A national resource of human tissue samples. Rand, Santa Monica, DTIC DocumentGoogle Scholar
- 3.Fearn P et al (2013) 2012 International Society for Biological and Environmental Repositories Informatics Working Group: survey results and conclusions. Biopreserv Biobank 11(1):64–66CrossRefPubMedGoogle Scholar
- 4.Master Z et al (2012) Biobanks, consent and claims of consensus. Nat Methods 9(9):885CrossRefPubMedGoogle Scholar
- 5.Simeon-Dubach D, Watson P (2014) Biobanking 3.0: evidence based and customer focused biobanking. Clin Biochem 47(4–5):300–308CrossRefPubMedGoogle Scholar
- 6.Thompson A et al (2008) Evaluation of the current knowledge limitations in breast cancer research: a gap analysis. Breast Cancer Res 10(2):R26PubMedCentralCrossRefPubMedGoogle Scholar
- 7.Eccles S et al (2013) Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res 15(5):R92PubMedCentralCrossRefPubMedGoogle Scholar
- 8.Ollier W, Sprosen T, Peakman T (2005) UK Biobank: from concept to reality. Pharmacogenomics 6:639–646CrossRefPubMedGoogle Scholar
- 9.Biobank U (2007) UK Biobank: protocol for a large-scale prospective epidemiological resourceGoogle Scholar
- 10.Biobank U (2014) UK Biobank biomarker panel. 07/09/2014. Available from: http://www.ukbiobank.ac.uk/uk-biobank-biomarker-panel/
- 11.Biobank U (2014) UK Biobank Axiom Array. Available from: http://www.ukbiobank.ac.uk/scientists-3/uk-biobank-axiom-array/
- 12.Izzo M et al (2014) A digital repository with an extensible data model for biobanking and genomic analysis management. BMC Genomics 15(3):1–15Google Scholar
- 13.Wu H, Yamaguchi A (2014) Semantic Web technologies for the big data in life sciences. Biosci Trends 8(4):192–201CrossRefPubMedGoogle Scholar
- 14.1000 Genomes Project data available on Amazon Cloud (2014) 27 Sep 2014. Available from: http://www.nih.gov/news/health/mar2012/nhgri-29.htm